VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130, United States
NCT Number: NCT02248649
This project is investigating whether a home-based exercise program will reduce cognitive decline in patients with Parkinson's disease.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02130, United States
Background/Rationale:
Progressive cognitive impairment leading to dementia is an important component of Parkinson's disease (PD), contributing to significant levels of disability. The number of Veterans who will develop PD and, in turn, the number of Veterans with PD who develop dementia is likely to increase substantially. Given the profound negative health and social consequences associated with the development of dementia, it is critical to identify interventions that effectively slow the decline of cognitive function to prolong the time to onset of dementia. Based on the results of prior studies, physical activity is one of the few nonpharmacological interventions that holds promise in slowing cognitive decline.
Objective:
The investigators hypothesize that a home-based physical activity intervention to promote walking will reduce cognitive decline in Veterans with mild cognitive impairment in PD (PD-MCI).
Methods:
The proposed study is a randomized, controlled trial of a home-based walking intervention, evaluating effects on cognitive function. Community-dwelling Veterans with PD-MCI will be randomized to a walking intervention or a health education control intervention. Subjects will be male and female Veterans with a physician diagnosis of idiopathic, typical PD, with at least 2 of 3 cardinal signs of PD, response to dopaminergic medication, and MCI. The interventions will last 18 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Walking instruction and encouragement
Provision of general information about a variety of health topics
Time frame: Baseline and 6 months
The ADAS-Cog includes items assessing memory, orientation, language, and praxis. Scores range from 0-70 (higher scores indicate worse cognitive function). Change = Score at 6-month - Score at Baseline.
Time frame: Baseline and 12 months
The ADAS-Cog includes items assessing memory, orientation, language, and praxis. Scores range from 0-70 (higher scores indicate worse cognitive function). Change = Score at 12-month - Score at Baseline.
Time frame: Baseline and 18 month
The ADAS-Cog includes items assessing memory, orientation, language, and praxis. Scores range from 0-70 (higher scores indicate worse cognitive function). Change = Score at 12-month - Score at Baseline.
VA Office of Research and Development
Fed
A Telemedicine Intervention to Improve Cognitive Function in Patients With PD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03836963
Basal Ganglia Diseases, Brain Diseases
Hines, Illinois, United States
View Trial DetailsNCT02048605
Basal Ganglia Diseases, Brain Diseases
Basel, Switzerland
View Trial DetailsNCT03243214
Basal Ganglia Diseases, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT01340885
Basal Ganglia Diseases, Brain Diseases
Portland, Oregon, United States
View Trial Details